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 1 
SYNOPSIS 2 
 3 
Alone among countries in the Group of G20, the age-standardized burden of vision loss from 4 
eye disease in China has risen over the last 25 years. 5 
 6 
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 1 
Abstract 2 
 3 
Aims To assess the burden of vision loss due to eye disease in China between 1990 and 2015, 4 
and to predict the burden in 2020. 5 
 6 
Methods Data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 7 
(GBD 2015) were used. The main outcome measures were prevalence and Years lived with 8 
disability (YLDs) for vision loss due to Cataract, Glaucoma, Macular degeneration, Other 9 
vision loss, Refraction and accommodation disorders and Trachoma. 10 
 11 
Results Prevalence for eye diseases increased steadily from 1990 to 2015, and will increase 12 
till 2020. From 1990 to 2015, the most common eye disorder was Refraction and 13 
accommodation disorders. From 1990 to 2015, the vision loss burden due to eye disease 14 
decreased for those aged 0-14 years, and increased for those aged 15 years and above, with 15 
the most notable increases occurring among those aged 50 years and above. China ranked 16 
10th when comparing YLDs for vision loss due to eye disease with the other members of the 17 
G20. Age-standardized YLD rates for vision loss due to eye disease declined in all 19 18 
countries, except for China. The burden from vision loss due to eye disease ranked 12th and 19 
11th among all causes of health loss in China in 1990 and 2015 respectively. 20 
 21 
Conclusion Alone among major economies, China has experienced an increase in the burden 22 
of age-standardized vision loss from eye disease over the last two decades. In the future, 23 
China may expect a growing burden of vision loss due to population growth and ageing. 24 
 25 
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 1 
China has the world’s largest population, over 1.406 billion, accounting for nearly 20% of the 2 
earth’s inhabitants.1 China has made enormous strides in improving health in the past few 3 
decades: life expectancy at birth has steadily increased and the under-5 mortality rate has 4 
fallen sharply.2-4 At the same time, more needs to be done to further enhance the quality of the 5 
longer lives of China’s citizens. A comprehensive assessment of current and expected disease 6 
burdens can help to inform China’s health reform efforts, and provide evidence to support 7 
long-range strategies. 8 
 9 
Vision loss due to eye disease is a major health problem, greatly affecting quality of life. 10 
Globally as of 2015, 34.3 million people were blind, an additional 24.3 million had severe vision 11 
impairment, 214 million had moderate vision impairment, and 663 million had near vision 12 
impairment.5 Vision loss is the third largest cause of impairment after anemia and hearing 13 
loss,6 but the burden of vision loss in China remains unclear. The Global Burden of Diseases 14 
Study is the result of a worldwide collaboration aimed at quantifying various health metrics of 15 
loss to diseases and injuries. These metrics enable comparison of health data across 16 
boundaries of geography and time in a way that is more comprehensive and internally 17 
consistent than possible with previous data sources.6-8 18 
 19 
Our study aims to quantify the burden of vision loss due to various eye diseases in China from 20 
1990 to 2015 using the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 21 
(GBD 2015), and also to predict the burden in 2020.    22 
 23 
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 METHODS 1 
 2 
Data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) 3 
from 1990 to 2015 were used to analyze the burden of vision loss due to eye disease in 4 
China.7 We searched and extracted related data from the website database 5 
(http://ghdx.healthdata.org), which was set up and shared by the Global Burden of Disease 6 
Study group. Details on the data, approaches to enhancing data quality and comparability, and 7 
statistical modeling and metrics for the GBD 2015 have been reported previously.6-9 In brief, 8 
the GBD study team collected data from household surveys archived in the Global Health Data 9 
Exchange, sources suggested by in-country experts, and surveys identified in major 10 
multinational survey data catalogues and Ministry of Health and Central Statistical Office 11 
websites. There were 38 studies included, and the full list of the studies has been uploaded as 12 
a Supplementary file (supplementary 1). Unpublished data and data from studies of Rapid 13 
Assessments of Avoidable Blindness (RAAB) were also included. GBD 2015 estimated 14 
incidence and prevalence of various conditions by age, sex, cause, year, and geography using 15 
a wide range of standardized analytical procedures, including data screening, data adjustment, 16 
DisMod-MR 2.1 estimation, and injury modeling strategies. The GBD investigators used 17 
numerous metrics to report results on health loss related to specific causes of disease and 18 
injury: deaths and death rates, years of life lost due to premature mortality (YLLs), years lived 19 
with disability (YLDs), and disability-adjusted life-years (DALYs).2,9 20 
 21 
The main outcome measures of our study were prevalence and YLDs associated with the 22 
vision loss burden due to various eye diseases. YLDs refer to years of life lived with any 23 
short-term or long-term health loss, which were equal to the prevalence of the eye disease 24 
multiplied by its associated disability weight.10 GBD 2013 included new data for disability 25 
weights, which quantify the severity of health loss associated with a particular disease.8 26 
Disability weights use numbers on a scale from 0 to 1 that represent the severity of health loss 27 
associated with a particular health state.8,10-12 The severity of health loss was based on 28 
surveys of the general public in five countries (Bangladesh, Indonesia, Peru, Tanzania, and the 29 
USA) and an open internet survey.8,10-12 YLD rates were calculated by dividing the number of 30 
years of life lost by the relevant population.10-12 Age-adjusted rates were calculated using the 31 
WHO 2000-2025 World standard population, which excluded the effects of total population 32 
size and age structure.8,9,12 The percentages for YLDs were calculated as the number of years 33 
lived with disability due to a specific disease divided by the total number of years lived with 34 
disability for all diseases.  35 
 36 
The following six ocular diseases were listed in the GBD 2015: Cataract, Glaucoma, Macular 37 
degeneration (including age-related macular degeneration, myopic maculopathy and other 38 
macular disorders), Trachoma, Refraction and accommodation disorders and Other vision 39 
loss.7 The other vision loss category included a total of 57 eye conditions.13 The changing 40 
trends of the burden of vision loss over time and with age were investigated. We also 41 
compared the burden of vision loss in China with the burden of other diseases and with the 42 
burden of vision loss in other countries.  43 
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RESULTS 1 
 2 
From 1990 to 2015, the most common eye disorder in China was Refraction and 3 
accommodation disorders (figure 1; supplementary 2), while the second most common was 4 
Cataract. It was followed by Other vision loss, then by Macular degeneration and Glaucoma, 5 
with Glaucoma being more common before 2005 and Macular degeneration more common 6 
after 2005. The prevalence for Trachoma was the lowest. All-age prevalences for all included 7 
eye diseases increased steadily from 1990 to 2015, and are projected to rise until 2020. 8 
Age-standardized prevalence rates for Refraction and accommodation disorders, Cataract and 9 
Other vision loss remained essentially unchanged, while age-standardized rates for Macular 10 
degeneration and Glaucoma increased slightly and those for Trachoma fell considerably.  11 
 12 
From 1990 to 2015, the vision loss burden due to eye disease decreased for those aged 0-14 13 
years, and increased for those aged 15 years and above, with the most notable increases 14 
occurring among those aged 50 years and above (figure 2; supplementary 3). The burden of 15 
vision loss due to every individual eye disease increased from 1990 to 2015 among those 50 16 
and above, with the prevalence ranking of diseases remaining unchanged for most conditions: 17 
Refraction and accommodation disorders (1st), Cataract (2nd), Other vision loss (3rd) and 18 
Trachoma (6th). In 1990, the prevalence of Glaucoma ranked 4th and Macular degeneration 19 
ranked 5th among those 50 and above, while in 2015, the prevalence of Macular degeneration 20 
ranked 4th and Glaucoma ranked 5th among this age group. Refraction and accommodation 21 
disorders accounted for the majority of the burden of vision loss in all age groups both in 1990 22 
and in 2015.  23 
 24 
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 1 
Table 1: All-age YLDs and age-standardized YLD rates for vision loss due to various eye 2 
diseases in 1990 and 2015 for 19 member countries of the Group of 20 (The 20th member is 3 
the European Union) 4 
 5 
Country name 
All-age YLD 
Total in 1990 
(thousands) 
All-age YLDs in 2015 Age-standardized 
YLD Rate in 1990 
( per 100 000) 
Age-standardized 
YLD in 2015 
Total 
(thousands) 
Rank 
Rate 
( per 100 000) 
Rank 
Argentina 60.6  83.4  16 200.2  184.3  13 
Australia 25.2  40.7  19 144.1  137.9  15 
Brazil 304.3  571.4  5 304.6  295.4  8 
Canada 32.3  50.6  18 112.5  111.4  19 
China 2047.6  3800.4  2 241.4  257.8  10 
France 96.8  127.4  14 143.2  134.4  16 
Germany 162.7  198.2  10 164.1  152.9  14 
India 2977.2  5358.2  1 574.4  539.0  1 
Indonesia 451.6  700.6  3 416.1  368.1  5 
Italy 143.7  192.6  11 207.3  193.9  12 
Japan 364.3  566.9  6 268.8  261.3  9 
Mexico 218.7  424.2  8 405.3  405.1  3 
Russia 507.6  615.4  4 327.9  317.0  6 
Saudi Arabia 38.5  78.7  17 420.4  371.0  4 
South Africa 106.2  176.1  12 430.5  420.7  2 
South Korea 90.6  150.4  13 267.9  254.0  11 
Turkey 138.0  223.1  9 348.7  314.8  7 
United Kingdom 99.1  114.9  15 142.2  132.7  17 
United States 313.9  444.2  7 116.5  115.0  18 
YLDs: years lived with disability 6 
 7 
We compared YLDs for vision loss due to eye diseases in China with that of the other 18 8 
member countries of the G20 (the 20th member is the European Union) (table 1). We found 9 
that all-age YLDs for the burden of vision loss  increased in all 19 countries between 1990 10 
and 2015. In 2015, China ranked 2nd for all-age YLDs, behind only India. In terms of the 11 
age-standardized YLD rates for vision loss burden, China ranked 10th. Age-standardized YLD 12 
rates for vision loss due to eye diseases declined between 1990 and 2015 in all 19 countries 13 
except China.  14 
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 1 
Table 2: Top 20 causes of all-age YLDs and Age-standardized YLD rates in China in 1990 and 2 
2015 3 
YLDs: years lived with disability 4 
 5 
In 1990 and 2015, the burden from vision loss due to eye disease ranked 12th and 11th 6 
respectively among all causes of health loss (table 2). Most burdens from various causes 7 
increased in 2015 compared with those in 1990, except for Iron-deficiency anemia and 8 
Ascariasis. Compared with that in 1990, the All-age YLD total in 2015 increased by 85.6%, the 9 
fifth-highest such increase. The Age-standardized YLD rate for the vision loss burden changed 10 
much less between 1990 and 2015, increasing by only 6.8%, which was the 6th-highest 11 
increase.  12 
Cause 
All Age YLD 
in 1990 
All Age YLD 
in 2015 
Percentage change 
in All age YLD  
between 1990 and 
2015 (%) 
Age-stand
ardized 
YLD Rate 
in 1990 
Age-stand
ardized 
YLD Rate 
in 2015 
Percentage change 
in Age-standardized 
YLD Rate between 
1990 and 2015 (%) 
Total 
(thousands) 
Rank 
Total 
(thousands) 
Rank 
Lower back pain 6824.4  1 10445.6  1 53.1  696.0  655.8  -5.8  
Neck pain 4948.6  3 9297.5  2 87.9  514.9  556.1  8.0  
Age-related and other hearing 
loss 
4784.0  4 8555.7  3 78.8  595.9  581.4  -2.4  
Major depressive disorder 4565.1  5 6681.2  4 46.4  425.4  426.8  0.3  
Diabetes mellitus 2793.7  10 5884.2  5 110.6  307.0  360.6  17.5  
Other musculoskeletal 
disorders 
3846.4  6 5867.0  6 52.5  361.7  371.3  2.7  
Iron-deficiency anemia 5615.4  2 4829.9  7 -14.0  456.5  413.4  -9.4  
Schizophrenia 2856.0    9 4543.7  8 59.1  262.9  274.1  4.3  
Migraine 3058.0  8 4127.0  9 35.0  265.6  265.6  0.0  
Anxiety disorders 3208.3  7 3804.6  10 18.6  276.6  267.3  -3.4  
Vision loss due to eye 
disease 
2047.6  12 3800.4  11 85.6  241.4  257.8  6.8  
Osteoarthritis 1477.8  14 3602.7  12 143.8  190.0  218.5  15.0  
Chronic obstructive pulmonary 
disease 
2634.1  11 2772.7  13 5.3  316.5  184.4  -41.7  
Dysthymia 1435.2  15 2300.2  14 60.3  143.0  143.2  0.1  
Drug use disorders 1291.2  16 2156.1  15 67.0  100.6  142.8  41.9  
Road injuries 726.9  23 1831.1  16 151.9  74.2  114.8  54.7  
Falls 1056.5  19 1606.7  17 52.1  107.4  105.9  -1.4  
Food-borne trematodiases 1237.4  17 1527.5  18 23.5  103.9  99.2  -4.5  
Bipolar disorder 1075.0  18 1410.9  19 31.3  90.8  91.2  0.4  
Alcohol use disorders 929.6  20 1363.9  20 46.7  80.4  85.0  5.7  
Ascariasis 1892.0  13 42.7  29 -97.7  164.4  3.0  -98.2  
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DISCUSSION 1 
 2 
Previous studies have usually focused on the prevalence of eye diseases alone to evaluate 3 
the burden of vision loss. Our study aimed to investigate the vision loss burden in China using 4 
both prevalence and YLDs, which enables the comparison of burden from vision loss with 5 
those from other diseases and in other countries.  6 
 7 
Our findings indicate that the burden of vision loss in China was dominated by Refraction and 8 
accommodation disorders, which is consistent with findings in other countries in the world.14-18 9 
Considering that most Refraction and accommodation disorders can be safely and 10 
inexpensively corrected, greater efforts should be made to tackle this problem. ‘VISION 2020: 11 
the Right to Sight’ aims to eliminate avoidable blindness by the year 2020. Refraction and 12 
accommodation disorders mostly belong to avoidable blindness and should be considered as 13 
a priority. The second-leading cause of vision loss burden was Cataract, which is also the 14 
leading cause for blindness in China.16,19 China’s cataract surgery rate (CSR) in2012 was 15 
1072/million/year, which was lower than rates for other countries in the region with lower per 16 
capita incomes than China, including Thailand, Vietnam, Laos, Kampuchea, and the 17 
Philippines.19 Tackling Cataract is still a great challenge in China, in part due to inadequate 18 
training opportunities for young surgeons.20,21  19 
 20 
Age-standardized prevalence rates reveal the true burden of eye disease, excluding the effect 21 
of population size and age structure. For the past 25 years, age-standardized prevalence rates 22 
for Refraction and accommodation disorders, Cataract and Other vision loss remained virtually 23 
unchanged, which is particularly concerning, given that these conditions are eminently 24 
treatable. Of even greater concern is the fact that age-standardized prevalence rates for 25 
Macular degeneration and Glaucoma actually increased over this period. Little progress has 26 
been made in controlling these eye diseases. Due to population growth and aging, the all-age 27 
prevalences for all major eye diseases in China increased dramatically between 1990 and 28 
2015, and are predicted to increase until 2020. Trachoma was the one exception, whose 29 
age-adjusted rate greatly decreased. This is consistent with the fact that WHO has recently 30 
certified China free of active trachoma. The ophthalmological data for the GBD were mostly 31 
provided by the Vision Loss Expert Group (VLEG). VLEG data showed that all-ages 32 
prevalences of involved eye diseases have been increasing (unpublished VLEG data, 2015), 33 
which is consistent with the results of the GBD. Meanwhile, VLEG showed that the 34 
age-standardized prevalence of blindness (presenting visual acuity <3/60) and moderate and 35 
severe vision impairment (MSVI; presenting visual acuity <6/18 but ≥3/60 in the better eye) 36 
were decreasing (unpublished VLEG data, 2015). VLEG and GBD described the problem of 37 
vision loss problem from slightly different and complementary perspectives. VLEG principally 38 
focused on eye disease and paid more attention to severe vision loss. GBD was concerned 39 
with public health and paid more attention to vision-related health loss. Combining the results 40 
from both VLEG and GBD, it can be inferred that progress has been made in controlling 41 
blindness and severe vision impairment, but less so with regard to mild vision loss. 42 
 43 
When we studied the vision loss burden by age group, it was encouraging that this fell 44 
10 
 
between 1990 and 2015 in the 0 to 14-year group. But in the age groups above 15 years, the 1 
vision loss burden has increased over this period, particularly among those above the age of 2 
50 years. The observed progress among younger ages may be due to China’s one-child policy, 3 
promulgated since the 1970s, and the resulting attention paid by families to the well-being of 4 
children. But this policy has also led to the rapid aging of China’s population, with the 5 
proportion aged 65 years and above growing from 5.51% in 1990 to 10.5% in 2015.22 Most 6 
common causes of vision loss are age related, such as cataract, glaucoma and macular 7 
degeneration. The ageing population plays a significant role in the increasing burden of vision 8 
loss, and national policy should give priority to controlling such eye diseases of aging. 9 
 10 
The burden of vision loss in China was somewhat less than that in India and was worse than 11 
those in other member countries of the G20. This was to be expected, taking China’s large 12 
population into account. However, it is worth noting that China was the only country whose 13 
age-standardized YLD rate for vision loss in 2015 was higher than that in 1990. This is quite 14 
concerning, as it shows that there has been little progress in controlling vision loss over the 15 
past 25 years. Further analysis shows that the following two diseases were the main causes 16 
for the rise: Macular degeneration and Glaucoma. VLEG data also indicate that the proportion 17 
of blindness that can be explained by macular degeneration increased from 5.0% in 1990 to 18 
6.9% in 2010, and for glaucoma increased from 3.9% in 1990 to 5.4% in 2010 in East Asia.16 19 
These are two diseases that have not yet been widely targeted by Chinese government 20 
programs. As noted above, there has been a significant increase in life expectancy in China 21 
over the past 25 years,2-4 which may have led to a higher prevalence of age-related eye 22 
disease. Myopia has recently increased rapidly in prevalence in China.23,24 It seems 23 
reasonable that myopic macular degeneration may also have increased. Again, this is a 24 
disease which has yet to be targeted by Chinese government programs. Changes in diet and 25 
reduced physical exercise may also play a role. The reasons for the higher age-standardized 26 
rates need to be clarified by future studies. 27 
 28 
The burden of vision loss due to eye disease ranked 12th in 1990 and 11th in 2015 among all 29 
causes of health loss in China. The real burden of vision loss may be even worse, as some 30 
diseases which damage visual function and lead to blindness, such as diabetic retinopathy, 31 
were not included in our study. Furthermore, rarer causes of vision loss among children such 32 
as congenital cataract and congenital glaucoma were not investigated in the GBD study. This 33 
is understandable, since very few population-based studies have included younger age groups, 34 
making it difficult to establish precise estimates.5 The burden of vision loss may be 35 
underestimated due to the scarcity of data for children younger than 15 years.2,5  36 
 37 
This study has several limitations. Although the GBD Vision Loss Expert Group made every 38 
effort to collect all published and unpublished data,5 the quantity and quality of data available 39 
are still limited, which could affect the accuracy of the estimated burden. Also, the estimated 40 
vision loss burden in GBD 2015 may be incomplete due to failure to include certain diseases, 41 
as noted above. Despite these limitations, GBD remains the most standardized and accurate 42 
system available to assess disease burdens across time and place, and across different 43 
diseases and injuries.    44 
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 1 
In summary, this study demonstrates that progress in controlling vision loss from eye disease 2 
in China has been sub-optimal over the last 25 years. In the future, China will face more 3 
serious population ageing as well as population growth and should thus expect to encounter a 4 
growing burden of vision loss. Effective policies and measures to address this rising burden 5 
should be a national priority. 6 
 7 
Contributors BW did the literature search, designed the study, collected and interpreted data, 8 
and contributed to the writing of this article. NC designed the study, interpreted data, and 9 
contributed to the writing of this article. RB collected and interpreted data, and contributed to 10 
the writing of this article. YL interpreted data, and contributed to the writing of this article. KC, 11 
AZ, MY, WD and MZ collected data. NW designed the study and contributed to the writing of 12 
this article. All authors gave final approval of the version to be published. 13 
 14 
Funding Ministry of Health of the People’s Republic of China (Grant Number 201002019). 15 
 16 
Competing interests None. 17 
 18 
 19 
12 
 
 1 
REFERENCES:  2 
1. National Bureau of Statistics of China. http://www.stats.gov.cn.  3 
2. Gonghuan Yang, Yu Wang, Yixin Zeng. Rapid health transition in China, 1990–2010: 4 
findings from the Global Burden of Disease Study 2010. Lancet 2013;381:1987–2015. 5 
3. Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 6 
1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 7 
2013. Lancet 2016;387:251-72. 8 
4. Wang Y, Li X, Zhou M, et al. Under-5 mortality in 2851 Chinese counties, 1996-2012: a 9 
subnational assessment of achieving MDG 4 goals in China. Lancet 2016;387:273-83.  10 
5. Stevens G, White R, Flaxman SR, et al. Global prevalence of visual impairment and 11 
blindness: magnitude and temporal trends, 1990-2010. Ophthalmology 12 
2013;120:2377-84. 13 
6. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, 14 
and national incidence, prevalence, and years lived with disability for 310 diseases and 15 
injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. 16 
Lancet 2016;388:1545–602. 17 
7. Global Health Data Exchange. http://ghdx.healthdata.org.  18 
8. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national 19 
incidence, prevalence, and years lived with disability for 301 acute and chronic diseases 20 
and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of 21 
Disease Study 2013. Lancet 2015;386:743–800. 22 
9. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae 23 
of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of 24 
Disease Study 2010. Lancet 2012;380:2163–96. 25 
10. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from 26 
disease and injury: disability weights measurement study for the Global Burden of 27 
Disease Study 2010. Lancet 2012;380:2129-43. 28 
11. Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of 29 
Disease 2013 Study. Lancet Glob Health 2015;3:e712–23. 30 
12. Murray CJL, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. 31 
Lancet 2012;380:2063-66. 32 
13. Lindsay NB, Chante K, John H, et al. Global Burden of Eye and Vision Disease as 33 
Reflected in the Cochrane Database of Systematic Reviews. JAMA Ophthalmol 34 
2015;133:25-31. 35 
14. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 36 
13 
 
2012;96:614–18. 1 
15. Bourne RPA, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in 2 
high-income countries and in Eastern and Central Europe: 1990–2010. Br J Ophthalmol 3 
2014;98:629–38. 4 
16. Wong TY, Zheng Y, Jonas JB, et al. Prevalence and causes of vision loss in East Asia: 5 
1990–2010. Br J Ophthalmol 2014;98:599–604. 6 
17. Keeffe J, Taylor HR, Fotis K, et al. Prevalence and causes of vision loss in Southeast Asia 7 
and Oceania: 1990–2010. Br J Ophthalmol 2014;98:586–91. 8 
18. Jonas JB, George R, Asokan R, et al. Prevalence and causes of vision loss in Central and 9 
South Asia: 1990–2010. Br J Ophthalmol 2014;98:592–8. 10 
19. Zhao J. To improve the cataract surgery rate is a pressing matter of prevention of 11 
blindness in China. Chinese Journal of Medicine 2013;93:3729-30. 12 
20. Young  AL, Jhanji V, Liang Y, et al. A survey of perceived training differences between 13 
ophthalmology residents in Hong Kong and China. BMC Med Educ 2015;15:158-64. 14 
21. Jiang Y, Luo L, Congdon N, et al. Who will be wielding the lancet for China’s patients in 15 
the future? Lancet 2016;388:1952-4. 16 
22. World Health Organization. World Health Statistics. 17 
http://www.who.int/gho/publications/world_health_statistics/en/index.html  18 
23. Liang YB, Friedman DS, Wong TY, et al. Prevalence and causes of low vision and 19 
blindness in a rural Chinese adult population: the Handan Eye Study. Ophthalmology 20 
2008;115:1965-72. 21 
24. Xu L, Cui TT, Yang H, et al. Prevalence of visual impairment among adults in China: The 22 
Beijing eye study. Am J Ophthalmol 2006;141:591-3. 23 
 24 
14 
 
 1 
FIGURE LEGENDS: 2 
 3 
Figure 1: Prevalence for various eye diseases from 1990 to 2020 in China. 4 
 5 
Figure 2: Distribution of prevalence for various eye diseases and YLDs from vision loss due to 6 
eye disease in China, by age, 1990 and 2015 (figure left: Prevalence; figure right: YLDs) 7 
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